Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC5 | O15392 | 18/20 | 0.62 |
| ▸ | SPR | P35270 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2071967 | 0.86 | BIRC5 (0.66) | BIRC5 | |
| SCHEMBL2071015 | 0.84 | BIRC5 (0.63) | BIRC5 | |
| SCHEMBL2071293 | 0.82 | BIRC5 (0.55) | BIRC5 | |
| SCHEMBL2071390 | 0.81 | BIRC5 (0.57) | BIRC5 | |
| SCHEMBL2071835 | 0.81 | BIRC5 (0.72) | BIRC5 | |
| SCHEMBL2070146 | 0.80 | BIRC5 (0.64) | BIRC5 | |
| SCHEMBL2071111 | 0.80 | BIRC5 (0.58) | BIRC5 | |
| SCHEMBL2070334 | 0.77 | BIRC5 (1.00) | BIRC5 | |
| SCHEMBL2069367 | 0.76 | BIRC5 (0.69) | BIRC5 | |
| SCHEMBL28527097 | 0.76 | BIRC5 (0.90) | BIRC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7910742-B2 | Survivin inhibitors | ABBOTT LABORATORIES (US) | 2011-03-22 | — | — | US | disclosed |
| US-20070072833-A1 | Survivin inhibitors | ABBVIE INC. | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070072833-A1 | Survivin inhibitors | XIAP, BIRC5, BIRC3 | BIRC5 2/4885SPR 1047/4885CYP2C9 4867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.